| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |